Big Data based genetics software
SOPHiA GENETICS is a health tech company democratizing Data-Driven Medicine to improve health outcomes and economics worldwide. By unlocking the power of new-generation health data for cancer and rare diseases management, the universal SOPHiA Platform allows clinical researchers to act with precision and confidence. The company’s innovative approach enables an ever-expanding community of over 1’000 institutions to benefit from knowledge sharing, fostering a new era in healthcare.
SOPHiA’s achievement is recognized by the MIT Technology Review’s “50 Smartest Companies”.
News about Sophia Genetics
SOPHiA GENETICS Announces Pricing of Initial Public Offering
SOPHiA GENETICS SA announced today the pricing of its initial public offering of 13,000,000 ordinary shares at a price of $18 per share.
SOPHiA GENETICS Raises $110 Million in Oversubscribed New Funding Round
Supporting the Company’s Global Expansion to Meet Growing Clinical and Biopharma Demand for Data-Driven Medicine